The Status Quo and Problems of Hysteroscopy in Fertility-sparing Therapy for Endometrial Cancer

Xuxin Huang,Guonan Zhang

DOI: https://doi.org/10. 3969／j. issn. 1674-0904. 2019. 02. 012

2019-01-01

Abstract:Endometrial cancer is a worldwide malignant tumor of female genital tract. Although postmenopausal women are still at high risk of endometrial cancer, about 3% ~14% of endometrial cancer occurs in women under 40 years old. The standard treatment of endometrial cancer is total hysterectomy plus bilateral adnexal resection plus pelvic／abdominal aortic lymph node dissection. Although the treatment and prognosis are good, patients will permanently lose reproductive function. Young endometrial cancer patients are eager to retain reproductive function while expecting to cure the cancer. Therefore, how to carry out conservation treatment for young patients with endometrial cancer safely and effectively attracts the attention of clinicians. In recent years, many clinical reports have confirmed the effectiveness and safety of hysteroscopy in conserva-tion treatment and follow-up of young patients with endometrial carcinoma. However, as a surgical method, there are still many problems and controversies over hysteroscopy, and its clinical use still needs to be further explored and standardized.